Repligen | RGEN - Выручка от реализации





Продажи Изменить Дата
Agilent USD 1.84B 37M 2026-03
Align Technology USD 1.04B 10M 2026-03
Bio Techne USD 311.4M 15.5M 2026-03
BioMarin Pharmaceutical USD 766M 109M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Bruker USD 823.4M 153.8M 2026-03
Charles River Laboratories USD 995.8M 1.6M 2026-03
Danaher USD 5.95B 890M 2026-03
Dentsply International USD 880M 81M 2026-03
General Electric Aerospace USD 11.6B 270M 2026-03
Henry Schein USD 3.37B 30M 2026-03
Illumina USD 1.09B 70M 2026-03
IQVIA Holdings USD 4.15B 210M 2026-03
Mettler Toledo International USD 947.13M 182.87M 2026-03
Myriad Genetics USD 200.4M 9.4M 2026-03
OraSure Technologies USD 26.76M 322K 2025-12
Pacific Biosciences Of California USD 44.64M 6.2M 2025-12
Pfizer USD 14.5B 3.08B 2026-03
Repligen USD 194M 3.91M 2026-03
Revvity USD 711M 61.06M 2026-03
Standard Biotools USD 21.1M 2.7M 2026-03
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
Waters USD 1.27B 338M 2026-03
West Pharmaceutical Services USD 844.9M 39.9M 2026-03